Get started

Chart patterns

NLTA: Should be heading to retest recent high of $200Healthcare sector seems bullish overall. Lots of stocks within this sector have bullish bias as well. NTLA have a pretty well defined ABCDE Triangle pattern, and any time now is a good time to enter. Stop loss below the low of C i.e. around $140. Disclaimer: I'm not giving any trading and investing advice. I'm just sharing my chart observations. If you have any symbols that you'd like me to analyze, feel free to drop me a comment.
NASDAQ:NTLALong
by leslieyimsm
6
$CHPTEven with the electric vehicle revolution in full swing, not everyone sees the bull thesis for ChargePoint. Indeed, CHPT stock was cut in half from the the beginning of 2021 to mid-September, so clearly investor sentiment is at a low point. This could present an opportunity for folks with a tolerance for volatility. After all, the essence of contrarian investing is to get excited when others are fearful. There’s something about the $20 price point — it’s like a magnet for CHPT stock in 2021. Without a doubt, it’s probably frustrating for the long-term stockholders. As you may recall, ChargePoint shares propelled as high as $44.50 in January of this year. The sentiment was riding high, but it wasn’t the best time to take a long position. CHPT stock slipped to $20 in March. Believe it or not, the stock rose and fell back to that same $20 level in April, and then again in May, and once more in August. As of Sept. 23, it was back to $20 and change yet again. At least we can say there’s strong support at that level. When we look at the chart you can see price has been stuck in a fall wedge foe quite sometime now. As it comes to the end of it’s pattern and sits right at long term support it might be something you want to keep your eyes on for a break to the upside. Along with that, you also have the MACD flat. RSI below 50. I suggest keeping this on your watchlist. - Factor Four
NYSE:CHPTLong
by TheBlankFund
2
S&P500: Pullback before a probable 200 points drop?This might be part of news play or is it? So, there's 2 scenarios that this can play out. 1. Market is going to rally to 4450 area, and then drop the 200 points *White 12345 = Daily impulse. Yellow 12345 + Green ABC = 4H complete cycle. Supply & Demand Zones as reversal areas. OR 2) Market continues to rally up past 4500, signaling trend continuation **Red ABC = Daily retracement Blue 12345 = Wave 1 on Daily/ Impulse wave on 4H Crucial juncture is how the market reacts when it reaches 4450. If it goes side ways, then scenario 2 will most likely play out. If there's a selloff, then scenario 1. As for the rest of today, let's continue to buy :) Disclaimer: I'm not giving any trading and investing advice. I'm just sharing my chart observations. If you have any symbols that you'd like me to analyze, feel free to drop me a comment.
U
by leslieyimsm
23
$EFTR SAN DIEGO, Sept. 16, 2021 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics (NASDAQ: EFTR), a leader in the development of selective translation regulator inhibitors (STRIs) for the treatment of cancer, today announced that company management will participate in a fireside chat at the 2021 Cantor Virtual Global Healthcare Conference at 2:40 p.m. ET on Tuesday, September 28, 2021. eFFECTOR will also host investor meetings throughout the conference. A live webcast of the fireside chat will be available on the "Events and Presentation" page of the Investors section of the Company’s website. A replay of the webcast will be available for 30 days following the event. For more information, please visit investors.effector.com. About eFFECTOR Therapeutics eFFECTOR is a clinical-stage biopharmaceutical company focused on pioneering the development of a new class of oncology drugs referred to as STRIs. eFFECTOR’s STRI product candidates target the eIF4F complex and its activating kinase, mitogen-activated protein kinase interacting kinase (MNK). The eIF4F complex is a central node where two of the most frequently mutated signaling pathways in cancer, the PI3K-AKT and RAS-MEK pathways, converge to activate the translation of select mRNA into proteins that are frequent culprits in key disease-driving processes. Each of eFFECTOR’s product candidates is designed to act on a single protein that drives the expression of multiple functionally related proteins, including oncoproteins and immunosuppressive proteins in T cells, that together control tumor growth, survival and immune evasion. eFFECTOR’s lead product candidate, tomivosertib, is a MNK inhibitor currently being evaluated in KICKSTART, a randomized, double-blind, placebo-controlled Phase 2b trial of tomivosertib in combination with pembrolizumab in patients with metastatic non-small cell lung cancer (NSCLC). Zotatifin, eFFECTOR’s inhibitor of eIF4A, is currently being evaluated in Phase 2a expansion cohorts in certain biomarker-positive solid tumors, including ER+ breast cancer and KRAS-mutant NSCLC. eFFECTOR has a global collaboration with Pfizer to develop inhibitors of a third target, eIF4E. In addition to the company’s oncology focus, zotatifin is being evaluated as a potential host-directed anti-viral therapy in patients with mild to moderate COVID-19 in collaboration with the University of California, San Francisco, under a $5 million grant sponsored by the Defense Advanced Research Projects Agency. eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors (STRIs) for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of MNK1/2 that is in phase 2b clinical trial for the treatment of patients with metastatic non-small cell lung cancer (NSCLC). The company is also developing Zotatifin, a small molecule designed to inhibit eukaryotic initiation factor 4A (eIF4E), which is in phase 1/2 clinical trial to treat patients with solid tumors. It has a collaboration agreement with Pfizer Inc. to develop inhibitors of eIF4E. The company was founded in 2012 and is headquartered in San Diego, California.
ELong
by BADQOMOCAWGOWLD
$USDCAD - Different scenariosHi guys! 👋🏻 🔔 FOMC announcements are important today. The most important note expected from the FED Chairman would be announcement of the tapering asset purchases by the FED. The no-clue tapering asset purchases date might play a negative role to the US Dollar Index and since there will be a volatility, USD/CAD may jump to $1.2890 level and retrace to $1.2720 level pushed by the dynamic resistance of previous highs. 🔔 If the announcements are positive and the FOMC economic projection strengthens the confidence of investors in the US Dollar, then we might witness the USD/CAD’s continuation of an uptrend up to $1.29940 and $1.30900 levels, following an expanding diagonal pattern. 🔔 The second scenario looks least likely but indeed should be considered, this might take place if during the FOMC announcement rate hikes are adverted. In this case, in fear of rate hikes, the market might defect the US Dollar and USD/CAD might drop to $1.2580 and $1.2540 levels. 🔔 RSI and MACD indicators on a 4H USD/CAD signal the correction, namely a drop. RSI remains near overbought levels which show a decline when connecting the last three peaks. Key takeaways from the technical analysis are to watch the retest of the dynamic resistance of August 21, if USD/CAD closes above this level, the uptrend continuation will most likely take place with higher impulse. If there is a rejection, USD/CAD will correct to $1.2800 and $1.2720 below that. ✊🏻 Good luck with your trades! ✊🏻 If you like the idea hit the 👍🏻 button, follow me for more ideas.
by azizelliott
1
$BKYILeading Cybersecurity Provider BIO-key Partners with Intelisys, Expanding Channel Alliance Partner Program and Market Reach BIO-key International, Inc., together with its subsidiaries, develops and markets fingerprint identification biometric technology, enterprise-ready identity access management solutions, and software solutions to commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premise SaaS application, as well as windows device authentication through IAM platform. Its solutions enable its customers to secure their workforces and student populations; and make their partner networks more collaborative. In addition, it provides BIO-key VST and WEB-key products; and Civil and Large-Scale ID Infrastructure solutions develops finger-based biometric technology. Further, it offers finger scanners for enterprise and consumer markets under SideSwipe, EcoID, and SidePass brand names. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey.
NASDAQ:BKYILong
by BADQOMOCAWGOWLD
$APT Long term PT 40 and higherThe US Department of Health and Human Services has posted a notice of intent for the procurement of approximately 381 million surgical masks to be used in healthcare setting. Alpha Pro Tech, Ltd., together with its subsidiaries, develops, manufactures, and markets a range of disposable protective apparel, infection control, and building supply products in the United States and internationally. The company operates through two segments, Disposable Protective Apparel and Building Supply. The Disposable Protective Apparel segment provides shoe covers, bouffant caps, coveralls, frocks, lab coats, and gowns, hoods, as well as face masks and shields. The Building Supply segment offers construction weatherization products, such as housewrap, synthetic roof underlayment, and other woven materials. The company markets its products under the Alpha Pro Tech brand name, as well as under private labels. Its products are used primarily in cleanrooms; industrial safety manufacturing environments; health care facilities, such as hospitals, laboratories, and dental offices; building and re-roofing sites; and pharmaceutical markets. The company distributes its products through a network of purchasing groups, distributors, and independent sales representatives, as well as through its sales and marketing force. Alpha Pro Tech, Ltd. was founded in 1983 and is headquartered in Markham, Canada.
AMEX:APTLong
by BADQOMOCAWGOWLD
1
$RWLK Long term PT 6 and higherReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes wearable robotic exoskeletons for individuals with mobility impairments or other medical conditions in Israel, the United States, Europe, the Asia-Pacific, Latin America, and Africa. It offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for used in the rehabilitation of individuals with lower limb disability due to stroke; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers, institutions, and individuals, as well as through distributors. The company was formerly known as Argo Medical Technologies Ltd. and changed its name to ReWalk Robotics Ltd. ReWalk Robotics Ltd. was founded in 2001 and is headquartered in Yokneam Ilit, Israel.
RLong
by BADQOMOCAWGOWLD
3
Bitcoin: To the moon!?!?!If my wave counts are correct, this is how I forecast it will play out. Yellow line = Currently at Wave 2 based on weekly chart. Hence, it'll just be an ABC correction on the Daily chart. 12345 = Classic 5 impulse wave count on the Daily i.e Wave 1 on the Weekly I put a lower C placement just because there's a stronger Demand Zone. However, it might turn out to be a flat retracement i.e. C being the same level as A. Given the volatility with Bitcoin, it just might spike down to Demand Zone and rebound up quickly! After that, we should see new ATH!!! And that's just Wave 3 on the Weekly...who knows if there'll be extension waves carrying it to higher fib. numbers! Nonetheless, it's never a straight line. Best to buy and HODL! :) Disclaimer: I'm not giving any trading and investing advice. I'm just sharing my chart observations. If you have any symbols that you'd like me to analyze, feel free to drop me a comment.
BITSTAMP:BTCUSDLong
by leslieyimsm
4
$ATER entry PT 11-11.35 Target PTs 23-43 and higherAterian, Inc., together with its subsidiaries, operates as a technology-enabled consumer products company in North America and internationally. It provides Artificial Intelligence Mohawk e-Commerce Engine, a software technology platform, which uses machine learning, natural language processing, and data analytics to design, develop, market, and sell products. The company's platform provides home and kitchen appliances; kitchenware, heating, cooling, and health and beauty products; and air quality appliances, such as dehumidifiers, humidifiers, and air conditioners under the hOmeLabs, Vremi, Xtava, RIF6, Aussie Health, Holonix, Truweo, Mueller, Pursteam, Pohl and Schmitt, and Spiralizer brands. It also sells essential oils. The company primarily serves individual online consumers through Amazon and other e-commerce platforms, as well as through its owned and operated websites and other marketplaces. The company was formerly known as Mohawk Group Holdings, Inc. and changes its name to Aterian, Inc. in April 2021. Aterian, Inc. was founded in 2014 and is headquartered in New York, New York.
NASDAQ:ATERLong
by BADQOMOCAWGOWLD
3
$CRXTClarus Therapeutics Holdings, Inc. operates as a men's health specialty pharmaceutical company that focuses on the development and commercialization of oral testosterone replacement therapy in the United States. It offers JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company has a licensing agreement with HavaH Therapeutics for product to treat androgen-dependent inflammatory breast disease and certain forms of breast cancer. Clarus Therapeutics Holdings, Inc. was founded in 2003 and is based in Northbrook, Illinois.
CLong
by BADQOMOCAWGOWLD
$SDCSmileDirectClub, Inc. operates as an oral care company. It offers clear aligner therapy treatment. The company manages the end-to-end process, which include marketing, aligner manufacturing, fulfillment, treatment by a doctor, and monitoring through completion of their treatment with a network of approximately 250 state licensed orthodontists and general dentists through its teledentistry platform, SmileCheck in the United States, Puerto Rico, Canada, Australia, the United Kingdom, New Zealand, Ireland, Hong Kong, Germany, Singapore, Spain, and Austria. It offers aligners, impression and whitening kits, whitening gels, and retainers; and toothbrushes, toothpastes, water flossers, SmileSpa, and various ancillary oral care products. The company was founded in 2014 and is headquartered in Nashville, Tennessee.
SLong
by BADQOMOCAWGOWLD
EUR/AUD Two potential scenarios: 1. Bullish If price finds bullish momentum we could see price break above the key resistance level of 1.6170 level. IF this happens, we could see price return to previous highs of 1.6380. 2. Bearish On the daily chart, we can see a possible head and shoulders structure forming. If the price rejects at key resistance (1.6170) we could see price return to the 1.5920 level. Fundamentally, I have a bullish bias on this pair due to the poor performance of AUD. Lets see what happens!
by francesgurton
1
AUD/CAD - ShortPotential for more downside as price reaches the area of previous support (0.9275 ish zone) Could we see price reject here? Looking for: - Rejection at descending channel resistance - Rejection at previous support zone (0.9275) - Rejection at 38.2% fib level If taken, this trade will be in agreement with the overall downward trend of this pair (under the 200 day EMA) and in bearish confluence with the RVI and MACD for precise entry. AUDCAD has also been a very bearish pair recently.
Short
by francesgurton
PUNDIXUSDT: Just like Bitcoin (Requested by JCLARK87)Analysis is the same as my earlier BTCUSD post. We will have to see how wave B plays out. We shall evaluate again after its completion. There are lots of variations to pullback but as long as it is a pullback, it means it will still go higher. If it changes course to become another 12345 impulse wave, then the story changes. Disclaimer: I'm not giving any trading and investing advice. I'm just sharing my chart observations. If you have any symbols that you'd like me to analyze, feel free to drop me a comment.
Long
by leslieyimsm
2